MENU
CARM
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Carisma Therapeutics (CARM) Ownership - Who owns Carisma Therapeutics?
Profile
Industry
N/A
Address
3675 Market Street
Phone
+1 267 491-6422
Employees
107
Web
https://www.carismatx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
19.38M
P/E Ratio
N/A
Total Cash
26.88M
Projected Growth
N/A
Total Debt
3.32M
Revenue
20.27M
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
0.64
Total Debt/Equity
N/A
Revenue/Share
0.49 USD as % of share price
Fundamentals
CARM
Capitalization
19.4M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
26.9M
Total Cash/Share
0.64
Total Debt
3.32M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.49%
Revenue
20.3M
ROE
N/A
Book Value
-11.13M
P/B Ratio
114.94
Cash Flow
N/A
Earnings
-1.52
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
41K
Current Ratio
3.23
Current Revenue Per Employee
49779.41
Dividends Per Share - Security
N/A
EBITDA
-63.37M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-85.73
Shares Held By Institutions
8.53M
Shares Outstanding - Current
41.8M
Total Liabilities
53.2M
Total Volume MTD
N/A
Value
-1
Gain YTD
-84.160
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
3675 Market Street
Phone
+1 267 491-6422
Employees
107
Web
https://www.carismatx.com